Being a student at UCL is about so much more than just acquiring knowledge. Studying here gives you the opportunity to realise your potential as an individual, and the skills and tools to thrive.
Find out more about what makes UCL research world-leading, how to access UCL expertise, and teams in the Office of the Vice-Provost (Research, Innovation and Global Engagement).
Discover the many ways you can connect with UCL, and how we work with industry, government and not-for-profit organisations to tackle tough challenges.
Founded in 1826 in the heart of London, UCL is London's leading multidisciplinary university, with more than 16,000 staff and 50,000 students from 150 different countries.
Nicholas McGranahan selected as EMBO Young Investigator 2020
As one of 30 new investigators selected for the prestigious EMBO programme, Dr McGranahan joins a vibrant network of researchers who have "demonstrated scientific excellence and are among the next generation of leading life scientists."
1 December 2020
Welcoming scientists for over 20 years, the European Molecular Biology Organization (EMBO) Young Investigator programme has a global reputation for excellence. The programme annually identifies and supports some of the most promising early-career life scientists at a critical stage of their careers. EMBO Young Investigators benefit from a variety of financial, training and networking opportunities for them and their lab members over a period of four years.
Researchers chosen for the programme are selected for their outstanding scientific acheivements.
Nicholas McGranahan leads the UCL Cancer Genome Evolution Research Group and co-leads the bioinformatics within the CRUK-UCL Lung Cancer Centre of Excellence and TRACERx team at UCL. The team's research is focused on using computational methods to explore the cancer development and anti-tumour immunity within an evolutionary framework. By looking into how cancers evolve, the Group have recently explored the importance of large-scale gross chromosomal aberrations in cancer, identifying consistent patterns across tumours and also uncovering the importance of whole-genome duplications to buffer harmful alterations.
Speaking of the annoucement, Dr McGranahan said: "I feel incredibly honoured to be selected as one of this year's Young Investigators – it is really a testament to the hard work of my team and our wonderful collaborators. I'm very much looking forward to being a part of the EMBO scientific community and the opportunities to develop our work."
Researchers at the Francis Crick Institute and UCL have established why some cancer cells exhibit an unusual phenomenon called whole genome doubling, where every chromosome is duplicated.
International dentistry prize awarded to UCL Eastman Fellow
Dr Junaid Saleem Malik of the UCL Eastman Dental Institute has won first prize at AIOP (Accademia Italiana di Odontoiatria Protesica) YOUNG 2025, becoming the first international participant to do so.
AI-assisted intelligent hearing system surpasses human ear in sound direction recognition
A new AI-assisted hearing device inspired by the human cochlea could advance hearing aid technology, offering improved sound and direction recognition.
